Biomedical subjects
S Ozsoylu
Publications and source records attributed to S Ozsoylu.
Thrombocytopenia in the newborn.
Explore the source record for details and available documents.
Megadose methylprednisolone for the treatment of myelofibrosis.
Explore the source record for details and available documents.
Idiopathic thrombocytopenic purpura in infants under 6 months of age. A retrospective study.
Explore the source record for details and available documents.
Megadose methylprednisolone for pure red cell aplasia.
Explore the source record for details and available documents.
Treatment of visceral leishmaniasis.
Explore the source record for details and available documents.
Mega-dose methylprednisolone for chronic idiopathic thrombocytopenic purpura.
Explore the source record for details and available documents.
Oral megadose methylprednisolone for childhood acute idiopathic thrombocytopenic purpura.
Explore the source record for details and available documents.
Antiplatelet antibodies in childhood idiopathic thrombocytopenic purpura.
Antiplatelet antibodies were shown by the Handin and Stossel method in the sera of all 103 patients with acute idiopathic thrombocytopenic purpura (ITP) and in 100 cases following recovery from it. These antibodies were also shown in the sera of all 46 patients with chronic ITP and 32 cases after recovery. The decrease in level of antiplatelet antibodies was significant in all these children following recovery (P less than 0.001 for acute ITP, P less than 0.05 for chronic ITP). Antiplatelet antibodies could be determined in 67 acute and 21 chronic ITP cases in thrombocytopenic phase and following recovery, which showed very significant decreases in levels in each case in a later period. Antiplatelet antibody levels corresponding to the thrombocytopenic phase and recovery in acute and chronic ITP were significantly higher than normal and thrombocytopenic control values (P less than 0.001 for each).
Natural killer cells in pure red cell aplasia.
Explore the source record for details and available documents.
Vitamin E treatment in triplicated alpha-globin gene-heterozygous beta-thalassemia.
Explore the source record for details and available documents.
Mega-dose intravenous methylprednisone for the treatment of onyalai: a case report.
Onyalai, a peculiar manifestation of idiopathic thrombocytopenic purpura characterized by a haemorrhagic bullae of the oral mucosa and lips, was diagnosed in a 1.5-month-old Turkish boy. He was treated with mega-dose intravenous methylprednisolone (30 mg/kg for 3 days) with prompt platelet response and improvement of oral mucosal findings.
Delayed splenic development or transient asplenia?
Explore the source record for details and available documents.
Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential.
Explore the source record for details and available documents.
The effects of glucocorticoids on lymphocyte numbers.
Explore the source record for details and available documents.
High doses of methylprednisolone for Kasabach-Merritt syndrome.
Explore the source record for details and available documents.
Ménétrier disease in a child.
Explore the source record for details and available documents.
Mega-dose methylprednisolone for aplastic anaemia.
Explore the source record for details and available documents.